Psychiatry Mental health Market Analysis and Reports | Australia Conference Series

Market Analysis - Psychiatry Mental Health 2020

Al Baraha Global Psychiatry and Psychology market contributes to $34.5 billion which includes major countries such as US (74%), Europe (64%), japan (8.3%), and UAE (7.8%).

Market Analysis for Abuse and Addiction Treatment

         The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%.

Market Analysis for Pediatric Medicines

          The global market for pediatric medicines reached $80.7 billion in 2013 and should reach $83.6 billion in 2014. This market is expected to reach about $100.7 billion by 2019, registering a compound annual growth rate (CAGR) of 3.8% from 2014 to 2019.

Market Analysis of Anti-Psychotic Drugs

              The global market for antipsychotic drugs should grow from $13.2 billion in 2018 to reach $14.5 billion by 2023 at a compound annual growth rate (CAGR) of 1.9% for the period of 2018-2023.

Market Analysis for CNS Biomarker Market

               The global CNS biomarker market is projected to reach $5.1 billion by 2020 from $3.1 billion in 2015, at a compound annual growth rate (CAGR) of 10.4%.

Fund Allotment to Psychiatry Research

NIHR- National Institute for Health Research- $1.05 bi

HBP- Human Brain Project - $ 1.3bi

BRI- Brain Research Initiative -$ 0.1 bi

Mental illness’ and ‘Mental disorder’ are the terms used to describe a spectrum of mental health and behavioral disorders in Australia. National Survey of Mental Health and Wellbeing was started in 1990 in Australia. The role of this survey is to measure the number of population and the amount of disability with mental health disorders and mental health services used by the people. The importance of fine mental state and its impact on Australians have long been recognized by the Australian government and every one state and territory governments. Over the last three decades, these governments have worked along, via the National Mental State Strategy, to develop mental state programs and services to raised address the mental state needs of Australians.

In 2015-16, Australian Institute of Health and Welfare was estimated that around $9.0 billion or $373 per person was spent on mental health-related services. Out of 9.0 billion USD $5.4 billion (59.8%) was funded by state and territory governments, $3.1 billion (35%) were funded by the Australian government and $466 million (5.2%) was funded by private health insurance funds.

Funding of Projects

Brain Research Initiative

Brain Research through Advancing Innovative technology is a research effort launched by the Obama Administration to map the human brain working. In FY 2014, a $100 million fund was issued in name of the National Institutes of Health.

National Institute for Health Research

In 2012/13, NIHR had a total research cost of £958.9m, research program’s- £208.9m and on infrastructure-£618.9m. The Faculty members of NIHR including senior investigators and fellowships received £100m.

Human Brain Project

The Human Brain Project is the one of the longest running project; the project cost is estimated at 1.19 billion euros and planned to last ten years (2013-2023).

PROJECTIONS: GROWTH IN NEXT 5 TO 10 years

Psychiatrists - Demand for Psychiatrists are projected to increase from ∼18,180 to 21,440 by 2025.

The Human Brain Project- The main goal of the HBP is to deliver a collaboratively built first draft "scaffold" model and simulation of the human brain by 2023.

Healthy People 2020- It is a statement of national health objectives designed to identify the most significant preventable threats to health and to establish national goals to reduce these Psychiatry problems.

WPA Member Societies and Sections plan to increase significantly the number of Psychiatrists in the near future, and to upgrade the pattern of distribution of the journal. In addition to the original English edition, a Chinese edition of the journal is already being produced. Contacts are ongoing for the production of Spanish, a Portuguese and a Japanese edition.

The journal is also produced in an electronic version, which is sent by email to the Presidents of all WPA Member Societies and the Chairpersons of all WPA Sections. This version is already included in the website of the WPA and of several of its Member Societies and Sections.

Global Burden of Disease: A collaborative Project (2005 to 2030)

WHO launched a number of global public health projects, including the Public Health and Global Initiative on Psychiatry and whose purpose is to increase professional and public awareness of the occurrence, extent and costs of disorders and to emphasize the need to provide Psychiatric & psychological care at all levels including primary healthcare.

Human Connectome

The NIH Human Connectome Project is an ambitious effort to map the neural pathways that underlie human brain function. The objective of Project is to acquire and share data about the structural and functional connectivity of the human brain.

ROOTS: Investigating the origins of adolescent psychopathology

The project will not restrict itself to the study of depression but will encompass many aspects of teenage mental health throughout the demanding adolescent period. The aim is to determine the relative contributions that specific genetic, physiological, psychological and social variables make to the overall risk for psychopathology during adolescence. Teenagers are recruited into the study at age 14 and will be followed through the adolescent period until they reach 17-18.

 

32nd International Conference on Psychiatry and Mentalhealth” which is going to be held on June 22-23, 2020 at Brisbane, Australia. The theme of the conference is “Exploring innovations and advancements in the field of Psychiatry and Mental Health”. This conference is going to cover the entire field related to Psychiatry and Mentalhealth, its complication and the management and it also cover what is the innovative treatment related to their disorders.  We are looking forward to being part of this collaborative gathering of key innovators and thought leaders from across the medical and health spectrum. For more information or for opportunities to attend, speak, or sponsor at this year’s conference